文献速递冠心病心力衰竭与心肌病

EMC10:骨髓来源的促血管生成生长因子促进心肌梗死后组织修复

EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.
PubMed 文献 · Circulation · 2017-09-20

该研究基于急性心肌梗死患者骨髓细胞分泌组分析发现EMC10,并在培养内皮细胞、梗死心脏外植体及多种小鼠模型中验证其促血管生成作用与机制。Emc10经小GTP酶、p21活化激酶及p38 MAPK-MK2通路促进内皮细胞迁移,骨髓来源单核细胞和巨噬细胞是梗死心脏中Emc10的主要来源。Emc10缺失加重梗死边缘区毛细血管化受损与左室重构,补充重组Emc10可改善重构,提示其可作为心梗后修复的潜在治疗靶点。

要点

  • Emc10由骨髓来源单核细胞和巨噬细胞产生,是心梗后内源性适应性反应的一部分。
  • Emc10经p38 MAPK-MK2通路促进内皮细胞迁移与梗死边缘区毛细血管化。
  • 补充重组Emc10可增强梗死边缘区毛细血管化并持续改善左室重构。

核心结论

  • Emc10是骨髓来源单核细胞和巨噬细胞产生的新型促血管生成生长因子,属于心梗后内源性适应性反应,可通过治疗性增强来修复心脏。

研究设计与样本

  • 在培养内皮细胞和梗死心脏外植体中研究EMC10及其小鼠同源物Emc10的促血管生成潜力。
  • 使用野生型、Emc10缺陷及Emc10骨髓嵌合小鼠行短暂冠状动脉结扎,明确心梗后Emc10的细胞来源与功能。
  • 在易发生心力衰竭的FVB/N小鼠中,经渗透泵递送重组Emc10评估心梗后治疗潜力。

主要发现

  • Emc10通过小GTP酶、p21活化激酶及p38 MAPK-MK2通路促进肌动蛋白聚合和内皮细胞迁移。
  • Emc10经p38 MAPK-MK2刺激梗死小鼠心脏外植体的内皮细胞向外生长。
  • 野生型小鼠心梗后左室梗死区和循环中Emc10蛋白丰度增加,急性心梗患者左室组织中Emc10表达亦增加。
  • Emc10 KO小鼠基线无心血管表型,心梗后梗死边缘区毛细血管化受损,梗死瘢痕更大、左室重构更明显。
  • 给KO小鼠移植野生型骨髓细胞可挽救血管生成缺陷并改善左室重构。

临床怎么用

  • Emc10及其下游p38 MAPK-MK2通路可作为心梗后促血管生成与组织修复的潜在治疗靶点。
  • 骨髓来源单核细胞和巨噬细胞来源的Emc10是心梗后内源性修复反应的一部分,提示可通过外源补充重组Emc10增强该反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical trials of bone marrow cell-based therapies after acute myocardial infarction (MI) have produced mostly neutral results. Treatment with specific bone marrow cell-derived secreted proteins may provide an alternative biological approach to improving tissue repair and heart function after MI. We recently performed a bioinformatic secretome analysis in bone marrow cells from patients with acute MI and discovered a poorly characterized secreted protein, EMC10 (endoplasmic reticulum membrane protein complex subunit 10), showing activity in an angiogenic screen. METHODS: We investigated the angiogenic potential of EMC10 and its mouse homolog (Emc10) in cultured endothelial cells and infarcted heart explants. We defined the cellular sources and function of Emc10 after MI using wild-type, Emc10-deficient, and Emc10 bone marrow-chimeric mice subjected to transient coronary artery ligation. Furthermore, we explored the therapeutic potential of recombinant Emc10 delivered by osmotic minipumps after MI in heart failure-prone FVB/N mice. RESULTS: Emc10 signaled through small GTPases, p21-activated kinase, and the p38 mitogen-activated protein kinase (MAPK)-MAPK-activated protein kinase 2 (MK2) pathway to promote actin polymerization and endothelial cell migration. Confirming the importance of these signaling events in the context of acute MI, Emc10 stimulated endothelial cell outgrowth from infarcted mouse heart explants via p38 MAPK-MK2. Emc10 protein abundance was increased in the infarcted region of the left ventricle and in the circulation of wild-type mice after MI. Emc10 expression was also increased in left ventricular tissue samples from patients with acute MI. Bone marrow-derived monocytes and macrophages were the predominant sources of Emc10 in the infarcted murine heart. Emc10 KO mice showed no cardiovascular phenotype at baseline. After MI, however, capillarization of the infarct border zone was impaired in KO mice, and the animals developed larger infarct scars and more pronounced left ventricular remodeling compared with wild-type mice. Transplanting KO mice with wild-type bone marrow cells rescued the angiogenic defect and ameliorated left ventricular remodeling. Treating FVB/N mice with recombinant Emc10 enhanced infarct border-zone capillarization and exerted a sustained beneficial effect on left ventricular remodeling. CONCLUSIONS: We have identified Emc10 as a previously unknown angiogenic growth factor that is produced by bone marrow-derived monocytes and macrophages as part of an endogenous adaptive response that can be enhanced therapeutically to repair the heart after MI.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Reboll MR, Korf-Klingebiel M, Klede S, et al. EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction. Circulation. 2017. PMID: 28931551. doi:10.1161/CIRCULATIONAHA.117.029980

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。